Stem Cells Spin S.A. (WSE:SCS)
Poland · Delayed Price · Currency is PLN 0.4000
0.00 (0.00%)
At close: May 15, 2026
Stem Cells Spin Revenue
In the year 2025, Stem Cells Spin had annual revenue of 65.74K PLN with 21.11% growth.
Revenue
65.74K
Revenue Growth
+21.11%
P/S Ratio
251.53
Revenue / Employee
65.74K
Employees
1
Market Cap
16.53M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 65.74K | 11.46K | 21.11% |
| Dec 31, 2024 | 54.28K | -365.04K | -87.06% |
| Dec 31, 2023 | 419.32K | 170.96K | 68.84% |
| Dec 31, 2022 | 248.36K | -277.56K | -52.78% |
| Dec 31, 2021 | 525.92K | 257.60K | 96.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| NEUCA | 13.64B |
| Diagnostyka | 2.42B |
| Synektik Spólka Akcyjna | 706.45M |
| Celon Pharma | 225.60M |
| genXone | 2.34M |
| InventionMed | 2.28M |
| Nestmedic | 1.05M |
| Medicofarma Biotech | 119.90K |